Asian hospitals join forces to personalize endometrial cancer care
NCT ID NCT07354087
First seen Jan 27, 2026 · Last updated Apr 26, 2026 · Updated 13 times
Summary
This study collects information from about 300 endometrial cancer patients treated across Asia between 2021 and 2023. Researchers want to see how different cancer cell features affect treatment choices, such as radiation or chemotherapy. The goal is to help doctors give the right amount of treatment—less for low-risk cancers and more for aggressive ones—while reducing side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Navi Mumbai, Maharashtra, 410210, India
-
Tata Memorial Hospital
Mumbai, Maharashtra, 400012, India
Conditions
Explore the condition pages connected to this study.